Euroapi S.A.
OTC: EAPIF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- David Seignolle
- Employees
- 3,187
- Headquarters
- Paris, France
- IPO year
- 2022
- Market cap
- $144.3M
- Website
- https://www.euroapi.com/en
Loading EAPIF…
Loading profile data…Frequently asked questions about EAPIF
What does Euroapi S.A. (EAPIF) do?
Established in 2021 and headquartered in Paris, France, Euroapi SA specializes in the end-to-end process, from development and manufacturing to marketing and distribution, of active pharmaceutical ingredients (APIs) and various intermediary compounds. These essential materials are then utilized in the formulation of a wide array of medicinal pro...
Where does EAPIF trade?
Euroapi S.A. (EAPIF) trades on the Other OTC.
What sector is EAPIF in?
Euroapi S.A. (EAPIF) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Euroapi S.A.?
David Seignolle is the chief executive officer of Euroapi S.A. (EAPIF).
Where is Euroapi S.A. headquartered?
Euroapi S.A. is headquartered in France.
Does EAPIF pay a dividend?
Euroapi S.A. (EAPIF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did EAPIF go public?
Euroapi S.A. (EAPIF) completed its initial public offering in 2022.